Does EVEROLIMUS Cause Neoplasm malignant? 316 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 316 reports of Neoplasm malignant have been filed in association with EVEROLIMUS (EVEROLIMUS). This represents 0.8% of all adverse event reports for EVEROLIMUS.
316
Reports of Neoplasm malignant with EVEROLIMUS
0.8%
of all EVEROLIMUS reports
71
Deaths
43
Hospitalizations
How Dangerous Is Neoplasm malignant From EVEROLIMUS?
Of the 316 reports, 71 (22.5%) resulted in death, 43 (13.6%) required hospitalization, and 5 (1.6%) were considered life-threatening.
Is Neoplasm malignant Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for EVEROLIMUS. However, 316 reports have been filed with the FAERS database.
What Other Side Effects Does EVEROLIMUS Cause?
Death (5,090)
Malignant neoplasm progression (3,789)
Diarrhoea (3,061)
Fatigue (2,946)
Stomatitis (2,692)
Nausea (2,079)
Dyspnoea (1,925)
Drug ineffective (1,837)
Pyrexia (1,664)
Decreased appetite (1,633)
What Other Drugs Cause Neoplasm malignant?
RANITIDINE (10,648)
ADALIMUMAB (2,028)
APIXABAN (1,772)
ETANERCEPT (1,616)
METHOTREXATE (1,041)
TOFACITINIB (1,020)
RITUXIMAB (929)
INFLIXIMAB (892)
ABATACEPT (727)
RISANKIZUMAB-RZAA (715)
Which EVEROLIMUS Alternatives Have Lower Neoplasm malignant Risk?
EVEROLIMUS vs EVOLOCUMAB
EVEROLIMUS vs EXELON
EVEROLIMUS vs EXEMESTANE
EVEROLIMUS vs EXENATIDE
EVEROLIMUS vs EXFORGE